Inflammation
Author:
Tirouvanziam Rabindra
Publisher
Springer Singapore
Reference72 articles.
1. Amore A, Formica M, Giacchino F, Gigliola G, Bonello F, Conti G, Camilla R, Coppo R (2013) N-acetylcysteine in hemodialysis diabetic patients resets the activation of NF-kB in lymphomonocytes to normal values. J Nephrol 26(4):778–786.
https://doi.org/10.5301/jn.5000167
2. Anrather J, Racchumi G, Iadecola C (2006) NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J Biol Chem 281(9):5657–5667.
https://doi.org/10.1074/jbc.M506172200
3. Antonioli L, Colucci R, Pellegrini C, Giustarini G, Sacco D, Tirotta E, Caputi V, Marsilio I, Giron MC, Nemeth ZH, Blandizzi C, Fornai M (2016) The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders. Expert Opin Ther Targets 20(2):179–191.
https://doi.org/10.1517/14728222.2016.1086752
4. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA (2007) N-acetylcysteine--a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 7(4):355–359.
https://doi.org/10.1016/j.coph.2007.04.005
5. Bertheloot D, Latz E (2017) HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol 14(1):43–64.
https://doi.org/10.1038/cmi.2016.34